FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 321:351-356 August 10, 1989 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We carried out a prospective, randomized, double-blind, placebo-controlled study to investigate the capacity of aspirin to prevent pregnancy-induced hypertension and to alter prostaglandin metabolism. A total of 791 pregnant women with various risk factors for pre-eclamptic toxemia were screened with use of the rollover test (a comparison of blood pressure before and after the woman rolls from her left side to her back) during week 28 or 29 of gestation. Of 69 women with abnormal results (an increase in blood pressure during the rollover test), 65 entered the study and were treated with a daily dose of either aspirin (100 mg; 34 women) or placebo (31 women) during the third trimester of pregnancy. The number of women in whom pregnancy-induced hypertension developed was significantly lower among the aspirin-treated than among the placebo-treated women (4 [11.8 percent] vs. 11 [35.5 percent]; P = 0.024); the same was true for the incidence of preeclamptic toxemia (1 [2.9 percent] vs 7 [22.6 percent]; P = 0.019). The mean ratio of serum levels of thromboxane A2 to serum levels of prostacyclin metabolites after three weeks of treatment decreased by 34.7 percent in the aspirin-treated group but increased by 51.2 percent in the placebo-treated group. No serious maternal or neonatal side effects of treatment occurred in either group. We conclude that low daily doses of aspirin taken during the third trimester of pregnancy significantly reduce the incidence of pregnancy-induced hypertension and pre-eclamptic toxemia in women at high risk for these disorders, possibly through the correction of an imbalance between levels of thromboxane and prostacyclin.

Source Information

Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.

This article has been cited by other articles:

• Erebara, A., Bozzo, P., Einarson, A., Koren, G. (2008). Treating the common cold during pregnancy. cfp 54: 687-689 [Abstract] [Full Text]  
• Carbillon, L., Uzan, S., Brenner, B. (2005). Early treatment with low-dose aspirin is effective for the prevention of preeclampsia and related complications in high-risk patients selected by the analysis of their historic risk factors. Blood 105: 902-903 [Full Text]  
• Norwitz, E. R., Repke, J. T. (2000). Preeclampsia Prevention and Management. Reproductive Sciences 7: 21-36 [Abstract]  
• Ananth, C. V., Berkowitz, G. S., Savitz, D. A., Lapinski, R. H. (1999). Placental Abruption and Adverse Perinatal Outcomes. JAMA 282: 1646-1651 [Abstract] [Full Text]  
• Caritis, S., Sibai, B., Hauth, J., Lindheimer, M. D., Klebanoff, M., Thom, E., VanDorsten, P., Landon, M., Paul, R., Miodovnik, M., Meis, P., Thurnau, G., Bottoms, S., McNellis, D., Roberts, J. M., The National Institute of Child Health Human Devel, (1998). Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk. NEJM 338: 701-705 [Abstract] [Full Text]  
• Barth, W. (1998). Low-Dose Aspirin for Preeclampsia -- The Unresolved Question. NEJM 338: 756-757 [Full Text]  
• Ioannidis, J. P.A., Cappelleri, J. C., Lau, J., Bent, S., Kerlikowske, K., Grady, D., Song, F.-J., Sheldon, T. A., Khan, S., Williamson, P., Sutton, R., Stewart, L. A., Parmar, M. K.B., Tierney, J. F., Sim, I., Lavori, P., Imperiale, T. F., LeLorier, J., Gregoire, G., Bailar, J. C. (1998). Meta-Analyses and Large Randomized, Controlled Trials. NEJM 338: 59-62 [Full Text]  
• Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., Depp, R., The National Institute of Child Health and Human D, (1993). Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women. NEJM 329: 1213-1218 [Abstract] [Full Text]  
• Kuban, K. C.K., Leviton, A., Pagano, M., Fenton, T., Strassfeld, R., Wolff, M. (1992). Maternal Toxemia Is Associated With Reduced Incidence of Germinal Matrix Hemorrhage in Premature Babies. J Child Neurol 7: 70-76 [Abstract]  
• Eskenazi, B., Fenster, L., Sidney, S. (1991). A Multivariate Analysis of Risk Factors for Preeclampsia. JAMA 266: 237-241 [Abstract]  
• Imperiale, T. F., Petrulis, A. S. (1991). A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease. JAMA 266: 260-264 [Abstract]  
• (1989). ASPIRIN REDUCES RISK OF TOXEMIA. JWatch General 1989: 3-3 [Full Text]